Since BACH2OE xenografts showed low leukemia burden in the BM (Fig. 1G), we then wondered whether these events are mediated by reduced CD28 and/or CD40LG levels in T-ALL cells upon BACH2 overexpression. The gene discussed is CD28; the disease is acute lymphoblastic leukemia.